Epilepsy-Epidemiology Forecast to 2027

Epilepsy-Epidemiology Forecast to 2027

  • DelveInsight
  • March 2018
  • Pharmaceutical
  • 50 pages

Report Description

DelveInsights Epilepsy - Epidemiology Forecast to 2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Epilepsy in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered
The United States
EU5 (Germany, France, Italy, Spain and the United Kingdom)

Study Period: 2016-2027

Epilepsy Epidemiology
The Epilepsy epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Epilepsy are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
According to DelveInsight, the prevalent cases of Epilepsy was 7,649,695 in 2016 in 7 MM and, is expected to increase at a CAGR of XX% during the study period i.e., 2016-2027. Among 7MM, United States account for highest prevalent cases of Epilepsy with 4,007,026 prevalent cases in 2016 followed by Germany.

Epilepsy Epidemiology Segmentation
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
The disease epidemiology covered in the report is segmented by sex-specific [Male and Female] and sub-type [Focal/ Partial, Generalized, Unclassified]. The report further covers prevalence of Tuberous Sclerosis Complex (TSC) associated Epilepsy.

Report Scope
The report covers detailed overview of Epilepsy explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
The report provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
The Report assesses the disease risk and burden and highlights the unmet needs of Epilepsy
The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
The report provides the segmentation of the disease epidemiology by gender and sub-types in 7MM

Key strengths
10 Year Forecast of Epilepsy epidemiology
7MM Coverage
Total Prevalent Cases of Epilepsy
Prevalent Cases according to segmentation: Gender-specific prevalence, sub-type specific prevalence and prevalence of Tuberous Sclerosis Complex (TSC) associated Epilepsy
Key assessments
Patient Segmentation
Disease Risk & Burden
Risk of disease by the segmentation
Factors driving growth in a specific patient population

Have query on this report?

Make an Enquiry
1. Report Summary 1
2. Epilepsy Disease Background 10
2.1. Introduction 10
2.2. Causes 11
2.3. Symptoms 11
Table 1: Prevalent Population of Epilepsy in the United States (2016-2027) 22
Table 2: Gender specific Prevalent Population of Epilepsy in the United States (2016-2027) 23
Table 3: Sub-type specific Prevalent Population of Epilepsy in the United States (2016-2027) 24
Table 4: Prevalence of TSC associated Epilepsy in the United States (2016-2027) 25
Table 5: Prevalent Population of Epilepsy in the Germany (2016-2027) 27
Table 6: Gender specific Prevalent Population of Epilepsy in the Germany (2016-2027) 28

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.


get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074